An adhesive treatment patch

WO2026215897A3PCT designated stage Publication Date: 2026-11-12DONNIE LIFE LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/IL2026/050320
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-04-08
Filing Date
2026-04-09
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing perineal protection devices during childbirth are limited in flexibility and often cause uncontrolled tearing due to the use of non-flexible fibers that stiffen the perineal anatomy, leading to longer recovery periods and potential long-term consequences.

Method used

An adhesive patch with a multilayered structure comprising a fine mesh adhesive layer, a therapeutic substance layer with supporting fibers, and a thermal energy source to deliver therapeutic substances, enhancing flexibility and limiting expansion, while incorporating a sensor module for monitoring and control.

Benefits of technology

The patch increases the flexibility of the perineal anatomy during childbirth, preventing uncontrolled tearing and maintaining the area moist and pliable, thereby reducing the risk of tears and supporting the perineum effectively.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure IL2026050320_12112026_PF_FP_ABST
    Figure IL2026050320_12112026_PF_FP_ABST
Patent Text Reader

Abstract

A wearable adhesive patch and a method for using the same, and in particular, to such an adhesive patch that is configured to mechanically support a treatment area.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] AN ADHESIVE TREATMENT PATCH

[0002] FIELD OF THE INVENTION

[0003] The present invention relates to a wearable adhesive patch and a method for using the same, and in particular, to such an adhesive patch that is configured to mechanically support a treatment area while delivering a therapeutic substance to the treatment area.

[0004] BACKGROUND OF THE INVENTION

[0005] Wounds on the surface of the human body and animal body are commonplace. Such wound are caused by some form of trauma that result in the laceration and / or cutting of the surface of skin. This generally occurs when the applied force stemming from the traumatic source is too large for the skin to absorb and / or overcome leading to a wound and / or rupture.

[0006] One such example occurs during childbirth, where the forces acting on the female anatomy is too large and the skin, particularly in the perineal anatomy often tears. Such tears require stitching and lead to a longer recovery period and at time long term consequences.

[0007] In order to overcome this problem has led to the introduction of various perineal protection devices operative to enhance tissue elasticity, provide support to tissue susceptible to tearing, and to redistribute forces generated during crowning.

[0008] An example of such advancements is introduced by Blurton et al, in U.S. Patent Publication No. US2014 / 0276919, and PCT Patent Publication No.

[0009] WO2019195097 to Langell et al., both teach a support stable support for the soft perineal tissues.

[0010] SUMMARY OF THE INVENTION

[0011] The present invention overcomes the deficiencies of the background art by providing an adhesive patch that is configured to support a treatment area while delivering a therapeutic substance to the treatment area, most preferably the present invention overcomes the deficiencies of the background by providing a device, system and method for accurately controlling and monitoring the elasticity, while further optionally limiting the expansion of a treatment area, and in particular the female perineal anatomy.Prior art devices are limited in that they attempt to prevent the forces acting on the perineal anatomy during childbirth. Particularly the prior art acts to stiffen the perineal anatomy by introducing reinforcing non-flexible fibers, that will counteract the forces acting during childbirth.

[0012] Embodiment of the present invention provide a device, system and method for increasing the flexibility of the perineum during childbirth, therein preventing perineal tears.

[0013] Embodiment of the present invention provide a device, system and method for limiting the expansion of the perineum near the rectum and in certain areas during childbirth, therein preventing perineal tears.

[0014] Embodiments of the present invention provide an adhesive treatment patch that may be utilized over, a portion of the body and / or a treatment area for example including but not limited to the female perineal anatomy during delivery and / or childbirth. The treatment patch is configured to increase the flexibility of the perineal anatomy while preventing the perineum for uncontrolled tearing and / or unwanted reshaping.

[0015] In embodiments increased flexibility of the perineal anatomy is further provided by introducing a therapeutic substance to the perineal anatomy. The therapeutic substance acts along the treatment area, for example including but not limited to the perineum to encourage flexibility while support fibers allow the flexibility up to an upper limit.

[0016] In embodiments, therapeutic substance may be provided from optional preparations and / or formulations that are configured for facilitating treatment of the treatment area, for example to increase the treatment areas flexibility and / or stretchability of the skin to maintain the treatment area moist and / or pliable.

[0017] In embodiments the therapeutic substance may comprise at least one or more active materials and / or therapeutic substance. In embodiments the therapeutic substance may for example include at least one or more selected from the group comprising: Perineum oil, Almond oil, Argan oil, Coconut Oil, Olive Oil, Shea Butter, Jojoba Oil, Creams and lotions containing collagen, Ointment or liquid with green tea, Niacinamide, Centella Asiatica, Squalane, Hyaluronic acid, Polyhydroxy Acids (PHA), Lactic Acid, Ceramides, Dimethicone, Edelweiss Extract, Oat, oat butter, Algae, Witch Hazel, Alpha Hydroxy Acid (AHA), Salicylic Acid (BHA),Propylene, Glycol, Caprylic / Capric Triglyceride, Urea, Aloe, the like or any combination thereof

[0018] In embodiments the present invention provides, an adhesive patch adapted for supporting a portion of skin and its underlying tissue structures, the device comprising:

[0019] a multilayered pad comprising at least three layers:

[0020] a first (proximal / skin side) layer in the form of a fine mesh adhesive layer; a second (medial / inner) layer comprising at least one therapeutic substance that is delivered / conducted to the underlying portion of skin layer; and wherein the second layer features supporting fibers that are associated with the at least one therapeutic substance and configured to be delivered to the portion of skin through the first layer;

[0021] a third (distal / outer) layer featuring a thermal energy generating source that is configured to provide thermal energy and sufficient to facilitate the delivery of the therapeutic substance to the portion of skin from the second layer through the first layer; and

[0022] a sensor module

[0023] In embodiments, the adhesive patch may be configured wherein the supporting fibers forming the second layer are arranged in at least two dimensions.

[0024] In embodiments, the adhesive patch may be configured wherein the therapeutic substance is configured to be delivered in a flowing fluid form at a temperature of about 37 degrees.

[0025] In embodiments, the adhesive patch may be configured wherein the thermal energy generating source is activated by at least one or more activation source selected from: an electromagnetic signal, electromagnetic wave, electromagnetic energy, pressure wave, application of mechanical pressure, signal from at least sensor, signal received from an external mobile communication and processing device, a light source, an acoustic energy source, communication signal received from an external processing device, or any combination thereof.

[0026] In embodiments, the adhesive patch may be configured wherein the therapeutic substance is temperature activated by ambient temperature of the portion of skin.In embodiments, the adhesive patch may be configured wherein the therapeutic substance is configured to have fluid flow properties at a temperature range from about 34 degrees Celsius and up to about 38 degrees Celsius.

[0027] In embodiments, the adhesive patch may be configured wherein the therapeutic substance is configured to have at least one of a sublimation point, or melting point, or evaporation point within a temperature range of about 34-38 degrees Celsius.

[0028] In embodiments, the adhesive patch may be configured to comprise at least two or more different therapeutic substance.

[0029] In embodiments, the adhesive patch may be configured wherein at least one dimension of the patch may be from 1.5 cm (centimeters) and up to about 4 cm (centimeters).

[0030] In embodiments, the adhesive patch may be configured wherein at least one dimension of the patch is controlled by folding portions of the patch onto itself.

[0031] In embodiments, the adhesive patch may be configured to be formed from a plurality of sub-segments. Optionally, the patch is formed from a plurality of subsegment that are associated with one another over the portion of skin.

[0032] In embodiments, the adhesive patch may be configured to be shaped according to a portion of the human or animal anatomy.

[0033] In embodiments, the adhesive patch may be configured to be shaped according to the female perineal and vaginal anatomy.

[0034] In embodiments, the adhesive patch may be configured, wherein a first subsegment is shaped corresponding to the external vaginal surface anatomy; and a second sub-segment is shaped corresponding to the perineal surface / anatomy.

[0035] In embodiments, the adhesive patch may be configured wherein the support fibers are configured to expand or contract along its long axis by up to 200% of its initial length.

[0036] In embodiments, the adhesive patch may be configured wherein support fibers are arranged in an overlapping configuration.

[0037] In embodiments, the adhesive patch may be configured wherein the support fibers have a geometric configuration selected from at least one of circular, square, triangular, polygonal of at least 3 sides, oval, ovoid, elliptical, braided, or any combination thereof.In embodiments, the adhesive patch may be configured wherein the support fibers have an overlapping configuration that is asymmetric.

[0038] In embodiments, the adhesive patch may be configured wherein the support fibers have an overlapping configuration that is symmetric.

[0039] In embodiments, the adhesive patch may be configured wherein the support fibers are provided from materials selected from: smart polymers, smart materials, smart alloys, shape memory materials, or any combination thereof.

[0040] In embodiments, the adhesive patch may be configured wherein the support fibers are coated or infused with the therapeutic substance.

[0041] In embodiments, the adhesive patch may be configured wherein the second layer comprises at least two sublayers including: a first sub-layer having support fibers arranged in a first orientation; and a second sub-layer having support fibers arranged in a second orientation that is orthogonal to the first fiber orientation. In embodiments, the adhesive patch may be configured to further comprise a third sub-layer having support fibers arranged in a third fiber orientation that is orthogonal to both the first fiber orientation and the second fiber orientation.

[0042] In embodiments, the adhesive patch may be configured wherein the sensor module comprises a Fetal Heart Rate (FHR) sensor .

[0043] In embodiments, the adhesive patch may be configured to comprise an electronics module. Optionally the electronics module includes a communications module configured to be in communication with an auxiliary device.

[0044] In embodiments, the adhesive patch may be configured wherein the thermal energy generating source is configured to provide thermal energy to the treatment area equivalent to 38 degrees Celsius for up to 3 hours.

[0045] Embodiments of the present invention provide a method for supporting a portion of skin with the adhesive patch according to embodiments of the present invention wherein the method comprises:

[0046] applying at least a portion of the adhesive patch with the adhesive layer over a treatment area comprising the female vaginal anatomy;

[0047] applying at least a portion of the adhesive patch over a treatment area comprising at least a portion of skin of the female perineal anatomy; andactivating the thermal energy generating source configured to facilitate mobilizing fluid flow properties of at least one or more therapeutic substance toward the treatment area.

[0048] Embodiments of the present invention provide a method for supporting a portion of skin with the adhesive patch according to embodiments of the present invention, wherein the method comprises:

[0049] applying at least a portion of the adhesive patch with the adhesive layer over a treatment area comprising the female vaginal anatomy or female perineal anatomy;

[0050] limiting the expansion of the treatment area with the support fibers wherein the support fibers are shaped so as to encourage the flexibility the support fiber along at least one or more axis; wherein the support fiber length is configured to self- adjusted by expansion or contraction by up to 200% of its initial length.

[0051] Embodiments of the present invention provide a kit for facilitating women during pregnancy and preferably during childbirth and most preferably during active childbirth. The kit comprising: at least one or more adhesive patch according to any embodiments of the present invention, at least one or more thermal energy generator(s), at least one or more therapeutic substances,

[0052] Optionally the kit may comprise at least one or more power source members for example including but not limited to a battery. Preferably the power source member is configured to be associated directly with a portion of the adhesive treatment patch.

[0053] Optionally the kit may comprise at least one or more sensor(s) that may be associated over the adhesive patch, optionally selected from: fetal heart rate sensor (FHR) 124, temperature sensor, pH sensor, galvanic skin conductance sensor, heart rate sensor, flow-meter, pulse oximeter, piezoelectric pressure sensor, pressure sensor, tension sensor the like or any combination thereof.

[0054] Optionally the kit may comprise a volume of at least one or more therapeutic substances comprising at least one or more active materials and / or therapeutic substance selected from the group comprising: Perineum oil, Almond oil, Argan oil, Coconut Oil, Olive Oil, Shea Butter, Jojoba Oil, Creams and lotions containing collagen, Ointment or liquid with green tea, Niacinamide, Centella Asiatica, Squalane, Hyaluronic acid, Polyhydroxy Acids (PHA), Lactic Acid, Ceramides, Dimethicone, Edelweiss Extract, Oat, oat butter, Algae, Witch Hazel, AlphaHydroxy Acid (AHA), Salicylic Acid (BHA), Propylene, Glycol, Caprylic / Capric Triglyceride, Urea, Aloe, the like or any combination thereof.

[0055] Most preferably the patch is configured to be associated over the perineum of a women during pregnancy, preferably during childbirth, optionally and preferably prior to the onset of the active childbirth phase, and most preferably at the onset of active childbirth, or the like.

[0056] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The materials, methods, and examples provided herein are illustrative only and not intended to be limiting.

[0057] Implementation of the method and system of the present invention involves performing or completing certain selected tasks or steps manually, automatically, or a combination thereof.

[0058] BRIEF DESCRIPTION OF THE DRAWINGS

[0059] The invention is herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of the preferred embodiments of the present invention only, and are presented in order to provide what is believed to be the most useful and readily understood description of the principles and conceptual aspects of the invention. In this regard, no attempt is made to show structural details of the invention in more detail than is necessary for a fundamental understanding of the invention, the description taken with the drawings making apparent to those skilled in the art how the several forms of the invention may be embodied in practice.

[0060] In the drawings:

[0061] FIG. 1 is a schematic block diagram of an exemplary device and system according to embodiments of the present invention; and

[0062] FIG. 2A is a schematic illustration of the multilayered pad according to embodiments of the present invention; and

[0063] FIG. 2B is a schematic illustration of the multilayered configuration of the pad featuring a plurality of sub-layers comprising support fibers, according to embodiments of the present invention; andFIG. 2C is a schematic illustration of the external layer of the pad featuring optional graduations and / or markings, according to embodiments of the present invention; and

[0064] FIG. 3 show a schematic illustration of a portion of a patch according to the present invention revealing the three dimensional configuration of support fibers, according to embodiments of the present invention; and

[0065] FIG. 4A-D shows schematic illustrations of a pad with optional support fibers dispersed therein according to optional embodiments of the present invention; FIG.

[0066] 4A shows a non-limiting examples of support fibers having a zig-zig configuration and double zigzag configuration; FIG. 4B shows a non-limiting example of a support fibers having overlapping circular configuration; FIG. 4C shows a non-limiting example of support fibers integrated with a therapeutic substance; FIG. 4D shows a non-limiting example of various optional support fiber configurations; and FIG. 5A-B shows a schematic illustration of the human body revealing the optional treatment areas; FIG. 5 A shows a schematic illustration of the human body; FIG. 5B shows a schematic illustration of a preferred treatment area comprising the female perineal anatomy; and

[0067] FIG. 6 is a schematic block diagram of an exemplary device according to embodiments of the present invention wherein the adhesive pad is configured from a plurality of patch sub-segments that are coupled and / or associated with one another over the treatment area; and

[0068] FIG. 7 is a schematic block diagram of an exemplary device according to embodiments of the present invention wherein the adhesive pad is configured from a plurality of patch sub-segments that are coupled and / or associated with one another using bridging support fibers; and

[0069] FIG. 8 is a schematic block diagram of an exemplary device according to embodiments of the present invention wherein the adhesive pad is configured from a plurality of support fibers having variable flexibility characteristics; and

[0070] FIG. 9A-C are schematic illustrative diagram of an exemplary device according to embodiments of the present invention wherein the adhesive pad is configured from a plurality of support fibers having variable expansion characteristics according to embodiments of the present invention; FIG. 9A shows a perspective view of the adhesive pad configured for the female perineum; FIG. 9B shows a partial exploded view of the adhesive pad revealing the various layers andsupport fibers; FIG. 9C is a close up view of the support fibers having variable expansion characteristics utilized to form an expansion gradient about the perineum of the female body.

[0071] DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0072] The principles and operation of the present invention may be better understood with reference to the drawings and the accompanying description.

[0073] The following figure reference labels are used throughout the description to refer to similarly functioning components are used throughout the specification hereinbelow.

[0074] 5 treatment area portion of skin and underlying tissue;

[0075] 20 auxiliary device;

[0076] 50 system;

[0077] 100 adhesive patch device;

[0078] 100a,b patch sub-segments;

[0079] 102 therapeutic substance;

[0080] 104 support fibers;

[0081] 104x,y,z directional oriented fibers;

[0082] 104b bridging / linking support fiber members;

[0083] 104i,ii,iii support fibers differing flexibility;

[0084] 105 multilayered pad;

[0085] 105a first layer (proximal, skin side);

[0086] 105b second layer (inner, medial);

[0087] 105c third layer (distal, outer layer);

[0088] 105bi,ii,iii sub-layers;

[0089] 106 thermal energy generating source;

[0090] 110 electronics module;

[0091] 111 user interface (UI) module;

[0092] 112 power supply module;

[0093] 114 controller and / or processor module;

[0094] 116 communication module;

[0095] 118 memory module ;

[0096] 120 sensor module;

[0097] 124 FHR sensor;Referring now to the drawings, FIG. 1 is a schematic block diagram of an exemplary device 100 and system 50 according to embodiments of the present invention for an adhesive patch configured to be removably attachable over a treatment area 5 by way of a biocompatible adhesive layer, most preferably the treatment area 5 comprising at least a portion of the female anatomy and in particular the female perineal anatomy.

[0098] In embodiment adhesive patch 100 comprises multilayered pad substrate 105, support fibers 104, therapeutic substance 102, a thermal energy source and / or generator 106, an electronics module 110 and a sensor module 120.

[0099] In embodiments adhesive patch 100 may be configured to be in communication with optional auxiliary devices 20 therein forming a system 50.

[0100] In embodiments adhesive patch 100 is provided in the form of a multi-layer pad 105 comprising at least two or more layers. In embodiments multi-layer pad 105 and / or portions thereof is preferably provided from transparent and / or clear and / or see-through material(s) so as to allow the treatment area 5 to be continuously visible.

[0101] In embodiments adhesive patch 100 may optionally be shaped according to a treatment area 5, FIG. 5A, so as to properly fit and couple thereto. For example, adhesive patch 100 configured for use with the female perineal anatomy, as shown in FIG. 5B, is preferably shaped to fit over the female genital anatomy and in particular the perineal anatomy.

[0102] In embodiments adhesive patch 100 ,may optionally be provided in optional shapes corresponding to the treatment area 5, most preferably the female perineal anatomy, for use during childbirth, wherein the patch 100 may be further configured to be provided in optional configuration most preferably corresponding to and specific to the position utilized during childbirth for example including but not limited to underwater delivery, side laying, back laying and / or reclining, squatting position, upright position, all fours position, lithotomy position, the like or any position as is known in the art. Most preferably, the adhesive patch is configured so as to optimize the fit for the users (patients) needs and caregivers (physician) to facilitate monitoring of the treatment area 5 for example including but not limited to the female perineal anatomy, preferably to monitor the flexibility of the treatment area. For example, patch 100 may be configured so that when the patch is not readily visible to the physician and / or user (patient), for example in a squatting position, the monitored data obtained with patch 100 is still accessible to both physician and user,for example implemented by utilized an audible user interface 111, for example in the form of a speaker to provide audible information to either one or both user and physician.

[0103] In embodiments adhesive patch 100 may be formed from at least two or more sub-portions 100a,b,c,d that may be coupled with one another, for example in a stacked manner, one on top of the other, and / or adjacently to one another, for example as shown in FIG. 6, such that the two or more sub-portion are coupled side by side to form the adhesive patch. Optionally two or more adhesive patch sub-portions 100a may be linked with one another with a bridging support fiber 104b, a non-limiting example of which is shown and described with respect to FIG. 7. Optionally each sub-portion may be configured to function independently functional. Optionally a plurality of sub-portion may be configured to function in unison. Optionally a plurality of sub-portions may be configured to function in a hierarchical, for example a master and slave configuration, wherein a first sub-portion is defined as the primary controlling sub-portion (i.e. master) while subsequent sub-portion(s) may be defined as secondary controlled sub-portion(s), (i.e. a slave).

[0104] In embodiments adhesive patch 100 may be configured to be transparent to allow a user and / or caregiver the ability to readily visualize the treatment area 5 over which device 100 is utilized

[0105] In embodiments adhesive patch 100 may be configured from materials that may be configured to be readily cut, for example, by use scissors, scalpel or the like cutting tool as is known in the art.

[0106] FIG. 5A and 5B shows a schematic illustration of the human body revealing the optional treatment areas 5 wherein patch 100 may be utilized, a preferred embodiment of the present invention for a patch 100 is configured to be used over a treatment area 5 comprising the female perineal anatomy 5 during labor as schematically shown in FIG. 5B.

[0107] FIG. 6 shows an optional embodiment of the present invention wherein adhesive patch 100 is realized in a multi -portion patch comprising a plurality of functionally coupled sub-patches 100a,100b,100c,100p for example as shown in FIG. 6 wherein a central sub patch 100c is configured to fit over the female vaginal anatomy an additional sub-patch lOOp configured to fit over the perineum of the female anatomy, as shown with respect to FIG. 5B, while optional flanking sub-patches 100a,b that may be configured to fit over adjacent portions flanking the respective vaginal and perineal anatomy.

[0108] FIG. 7 shows an optional embodiment of the present invention wherein adhesive patch 100 is realized as multi -portion patch comprising a plurality of functionally coupled sub-patches 100a to form device 100 for example as shown in FIG. 7 wherein a two sub patch 100a and 100b are coupled by bridging and / or linking support fibers 104b is configured to fit over a treatment area 5, most preferably the female perineal anatomy. A first sub-patch 100a is disposed near the vaginal opening at the anterior portion of the perineal anatomy and second sub-patch 100b is disposed near the anal opening at the posterior portion of the perineal anatomy therein forming an opening lOOo (and / or a treatment window / space) defined between the two subpatches 100a and 100b, for example a shown. In this configuration the treatment area 5, most preferably the female perineal anatomy, remains both visible and accessible to a caregiver, for example to apply a medicament, topical ointment, cream, apply massage, ultrasound imaging, the like or any combination thereof.

[0109] Optionally bridging support fibers 104b, are configured in the same manner as support fibers 104 so as to allow limited expansion and contraction up to about 100% of the fiber’s length. Optionally, bridging support fibers 104b may be placed in any direction and / or configuration and / or orientation between at least two or more sub-patchers 100a,b,c to form device 100, over any given treatment area 5 about the human or animal body. In embodiments support fibers 104, 104b may be configured to have an expansion limitation of up to 200% depending on the anatomy of the treatment area. In embodiments, support fibers 104,104b may be configured to have an expansion and / or contraction by up to about 250%, accordingly the support fiber contraction and / or expansion may be provided by a factor selected from one of about: 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 110%, 120%, 130%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, or a combination thereof. Optionally the support fiber 104,104b, utilized with device 100 may be selected based on the treatment area 5 and / or anatomy for which it is intended.

[0110] In embodiments the expansion and / or contraction limitation of support fiber 104, 104b utilized with device 100 may be of different levels in each direction and / or layer within which it is disposed, and may be at the same level in each direction and / or layer of device 100, for example as depicted in FIG. 4B.Now referring to FIG. 4B, that shows a schematic non limiting illustration of device 100, wherein the support fibers 104 are distributed along at least two dimensions of device 100. In embodiments, the level of flexibility of device 100 may be controlled based on the different support fibers 104 used and their placement about device 100.

[0111] In embodiments the level of flexibility of device 100 may be uniform, along each respective dimension of device 100. For example, as shown in FIG. 4B, the long axis may be provided with a uniform flexibility as shown with arrow Ax, and the short axis may be provided with a uniform flexibility as shown with arrow Ay. Optionally the flexibility of each dimension may be individually controlled based on the support fibers 104 such that flexibility Ax may be the same or different than that of Ay.

[0112] In embodiments the level of flexibility of device 100 may be non-uniform along at least one or more dimension of device 100. Accordingly, device 100 may be provided with areas and / or segments of different flexibility along any one or more dimension of device 100. A non limiting example is schematically shown in FIG. 4B wherein the long dimension of device 100 may be provided with at least two or more regions of different flexibilities as depicted by arrows Axi, Axii, and Axiii, wherein arrow Axi represent a segment having little flexibility, while arrow Axii represents a segment having more flexibility and arrow Axiii represents a segment having most flexibility. A similar non-limiting arrangement may also be provided about the short dimension of device 100 as shown with arrows Ayi, Ayii, wherein each represents a segment of different flexibility configuration along the short dimension. As would be understood by a skilled artisan the level of flexibility may be arranged as is necessary in any manner chosen and may be depicted based on the grade of flexibility as provided by the support fiber 104 utilized and the arraignment about device 100.

[0113] In embodiments, device 100 may comprise a mixture of support fibers 104 having variable degree(s) of contraction and / or expansion capabilities. For example, a first set of support fibers 104i may be configured to have up to 170% expansion of the original dimension, a second set of support fibers 104ii may be configured to have up to 150% expansion of the original dimension, and a third set of support fibers 104iii may be configured to have up to 120% expansion of the original dimension. Optionally each support fibers set / group 104i, 104ii, 104iii may be placed about different areas along the patch 100 optionally corresponding to locations about thetreatment area 5, most preferably the perineal anatomy. In embodiments the support fiber mixture may be provided such that each support fiber set 104i, 104ii, 104iii may be provided to correspond to different patch layers 105a, 105b, 105c. In embodiments the support fiber mixture assembly may be provided such that each support fiber set may be provided to correspond to different patch sub-segments 100a, 100b, 100c.

[0114] In embodiments the support fiber mixture assembly may be provided such that each support fiber set 104i, 104ii, 104iii, may be distributed about a specific segment and / or portion of device 100, for example as shown in FIG. 4B, such that different segments and / or portion of device 100 may be provided with different degrees of flexibility. Optionally and preferably the degree of flexibility of the different areas along device 100 preferably corresponds to each respective support fiber set 104i,ii,iii.

[0115] In embodiments the support fiber mixture assembly may be provided such that each support fiber set 104i,ii,iii may be oriented to correspond to different locations along the perineal anatomy, for example the first set 104i is provided adjacent to the vagina, and the third set 104iii is provided adjacent to the anus, therein providing a flexibility gradient orientation along at least a portion of the treatment area 5, and in particular the perineal anatomy, for example as shown in FIG. 8.

[0116] In embodiments the three dimensional arrangement of the support fibers 104, 104x,104y,104z are configured as such to allow the treatment area 5 (FIG. 5A-B), to be selectively flexible in a particular dimension and / or axis. For example, along the long dimension the support fibers may be less flexible while along the short dimension the support fibers may be more flexible, or vice versa. In embodiments this allows device 100 to be configured such that a treatment area 5, for example including but not limited to the female perineum as shown in FIG. 5B, may be sufficiently flexible to prevent perineal tearing while simultaneously preventing or facilitating to support the perineum from forming a concavity and / or pockets and / or assume a concave surface due to an internally applied force during childbirth, particularly during the active stages of childbirth, wherein the female perineum may be stretch to extends outwards to form a concavity and / or pocket by they head of the child. For example, this may be achieved by controlling the level of flexibility in at least two dimensions and more preferably along three dimensions.

[0117] In embodiments adhesive patch 100 comprises a multilayered pad 105 comprising at least two layers including a first layer 105a, and a second layer 105b.Optionally and preferably pad 105 further comprising a third layer 105c, a non limiting example of which is best seen in FIG. 2A.

[0118] In embodiments first layer 105a is provided in the form of an adhesive layer including a biocompatible adhesive that may be utilized to affix device 100 onto a treatment area 5 of a human or animal body, most preferably the female perineal anatomy. In embodiments, the first layer is a proximal side and / or skin side layer utilized for coupling and / or affixing and / or associating over the treatment area 5 comprising the skin of a human or animal body. Most preferably, adhesive layer 105a is provided in the form of a fine mesh layer.

[0119] In embodiments, second layer 105b is provided as supportive and / or structurally supportive member comprising support fibers 104 in optional orientation, a non-limiting example of which is depicted in FIG.3, FIG. 4A-D and schematically shown in FIG. 2B. In embodiments, optionally and preferably the second layer 105b may comprise and / or provided with a transparent support matrix, for example provided from thermoplastic polyurethane (‘TPU’) or the like material that are capable of associating and / or integrating and / or supporting the optional support fibers 104 so as to allow the embedded support fibers 104 to expand as necessary while remaining integrally formed with the transparent support matrix.

[0120] In some embodiments second layer 105b may be provided from a plurality of sub-layers 105bi, 105bii, 105biii, a schematic non-limiting example of which is depicted in in FIG. 2B. Optionally each sub-layer 105bi, 105bii, 105biii may be fit with support fibers 104 that are oriented in a different axis. For example, as shown in FIG. 2B, a first sub-layer 105bi may be fit with support fibers 104 that are oriented along the x-axis and noted as 104x; while a second sub-layer 105bii may be fit with support fibers 104 that are oriented along the y-axis and noted as 104y; while a third sub-layer 105biii may be fit with support fibers 104 that are oriented along the z-axis and noted as 104z, wherein optionally and preferably the support fibers 104x,y,z are configured to be orthogonal to one another.

[0121] In embodiments, support fibers 104,104b, 104x,104y,104z as utilized may be configured to have different mechanical and / or physical characteristics and / or properties as related to their at least one or more selected from: elasticity, relative expansion capability, expansion rate, flexibility, stiffness, contraction capability, contraction rate, the like or any combination thereof. In embodiments, any portionof device 100 featuring support fibers 104 may utilize optional support fibers 104 having the same or different mechanical characteristics.

[0122] In embodiments, the third layer 105c is provided as an outer layer and / or distal layer. Optionally, the third layer may be provided for housing at least one or more functional members comprising device 100. For example, third layer may feature the electronics and circuitry module 110, and / or sensor module 120, and / or thermal energy generating source 106, and / or therapeutic substance 102, Fetal Heart Rate sensor 124, the like or any combination thereof.

[0123] In embodiments third layer 105c may be provided with markings and / or graduations to facilitate measuring and / or monitoring a treatment area associated therewith, for example as shown in FIG. 2C. For example, third layer 105c may be provided with graduations to show any changes in dimension and / or stretch of the device 100 after it has been deployed over a given treatment area. For example, a third layer 105c comprising graduations and / or markings may provide a visual indicator to a care giver to what extent at least one or more layer has contracted and / or expanded during the use of device 100 over a treatment area. In embodiments, such markings could be provided an indicator when it is time to change and / or remove the pad 100. In embodiments the graduations and / or markings may be provided in at least one dimension, for example in the form of a ruler graduation(s) so as to show expansion and / or contraction along at least one dimension. In embodiments, the graduations and / or markings may be provided along two dimensions, for example in the form of a matrix so as to show expansion and / or contraction along at least two dimensions. In embodiments, the markings may be scaled according to any optional scale for example including but not limited to any one or more selected from linear, logarithmic, non-linear, exponential, the like or any combination thereof.

[0124] In embodiments, pad 105 may be configured to be a unitary member wherein its individual layers are compressed and / or pressed together to form a single identifiable pad 105, such that most preferably the individual layers 105a,b,c are indistinguishable from one another and therefore function as a cohesive pad member.

[0125] In embodiments pad 105 may be shaped according to any treatment site 5 and / or anatomy 5 for which it is intended to be associated over.

[0126] In embodiments, each pad may be provided from optional materials. Most preferably pad 105 and any layers thereof 105a,b,c may be provided from flexible elastomeric materials. Optionally elastomeric materials may for example include atleast one or more selected from the group comprising: rubber, thermoplastic elastomers (TPE), polymers, silicone rubber, acrylic rubber, ethylene containing rubber, Lycra, spandex, elastane, knitted materials, the like elastomers as is known in the art, or any combination thereof.

[0127] In embodiment pad 105 and layers 105a, b,c are preferably fit with supporting fibers 104 that may be dispersed in any one or more of layers 105a, b,c. Optionally supporting fibers 104 provide pad 105 with mechanical strength and support so as to gamer a portion of skin comprising the treatment area 5 and its underlying tissues so as to protect the treatment area from injury, damage, trauma, tearing, wounding by way of providing additional mechanical support. In embodiments support fibers 104 may further provide adhesive patch 100 and more specifically multilayered pad 105 with flexibility.

[0128] In embodiments support fibers 104 are provided from biocompatible materials and / or biocompatible smart materials, for example including but not limited to polymers, alloys, smart materials, shape memory materials, nitinol, materials exhibiting plastic deformation, super-elastic metal alloys which transforms from an austenitic state to a martensitic state, any combination thereof or the like as is known in the art.

[0129] In embodiments support fibers 104 may be provided from dedicated smart materials, shape memory materials that are configured to undergo a transition to assume different configurations when exposed to a transitioning condition, for example including but not limited to the application of force, pressure, heat exposure, acoustic signal, electromagnetic signal, electromagnetic wave, acoustic wave, magnetic field, temperature change, any combination thereof or the like.

[0130] In embodiments, support fibers 104,104b, 104x,104y,104z as utilized may be configured to have different mechanical and / or physical characteristics and / or parameters as related to their at least one or more selected from: elasticity, relative expansion capability, expansion rate, flexibility, stiffness, contraction capability, contraction rate, the like or any combination thereof.

[0131] In embodiments a transitioning and / or changing the elasticity and / or flexibility and / or rigidity of support fiber 104 may be provided when support fibers 104 are exposed to a transitioning condition and / or triggering event and / or agent and / or signal. Optionally the triggering condition may be selected from at least one or more from the group consisting of: exposure to a temperature change, exposureto a temperature increase, exposure to a temperature decrease, exposure to a chemical agent, exposure to a therapeutic substance, exposure to an electromagnetic field, exposure to an electromagnetic current, exposure to an acoustic signal, exposure to an optical signal, exposure to a magnetic field, and any combination thereof.

[0132] In embodiments support fibers 104 may be provided with optional shape configurations non-limiting examples of which are shown in FIG. 4A-D. In embodiments, support fibers 104 may be filaments having optional geometric configurations for example including but not limited to at least one or more selected from: a continuous linear fiber (FIG. 4D), intermittent linked linear fibers (FIG. 4D), crosslinked fibers, overlapping linear fibers, braided linear fibers (FIG. 4D, mesh fibers (FIG. 4D), zigzag fibers, double zigzag fibers, overlapping oval fibers, overlapping closed shaped geometric fibers, polygonal fibers having n sides wherein n is at least 3, circular fibers, overlapping square fibers, overlapping triangular, the like, or any combination thereof.

[0133] In embodiments, support fibers 104 may be provided as an overlapping fibers that are arranged in any symmetric and / or asymmetric configuration. For example, a symmetric configuration may comprise overlapping circular fibers at a constant degree of overlap. For example, an asymmetric configuration of overlapping fibers may be fibers having a variable degree of overlap between the overlapping circular fiber.

[0134] In embodiments support fibers 104,104b may be configured to expand and / or contract by up to about 100% of their length, and more preferably up to about 120% up to about 150% of the length, therein providing device 100 and pad 105 with the flexibility to support and reinforce the treatment site, in particular the female perineal anatomy during birth.

[0135] In embodiments support fibers 104,104b facilitate limiting the expansion of the perineum so that it may be stretched by a factor of up to 250%.

[0136] In embodiments, support fibers 104,104b may be configured to have an expansion and / or contraction of up to about 250%, accordingly the support fiber contraction and / or expansion may be provided by a factor selected from one of about: 30%, 40%, 50%, 60%, 70%, 80%, 90%, 100%, 110%, 120%, 130%, 150%, 160%, 170%, 180%, 190%, 200%, 210%, 220%, 230%, 240%, 250%, or a combinationthereof. Optionally the support fiber 104,104b, utilized with device 100 may be selected based on the treatment area 5 and / or anatomy for which it is intended.

[0137] In embodiments support fibers 104 may be distributed along pad 105, and / or any one layer 105a, 105b, 105c forming pad 105 in any directional configuration for example including but not limited to along the horizontal dimension, the vertical dimension, width, x-axis 104x (FIG. 2B); y-axis 104y (FIG. 2B), z-axis 104z (FIG.

[0138] 2B), grid-like, mesh, or in any combination thereof.

[0139] In embodiments support fibers 104 may be dispersed along pad 105 and / or any one layer 105a, 105b, 105c forming pad 105 in any manner for example including but not limited to symmetric, asymmetric, regular, irregular, randomized, the like or any combination thereof.

[0140] In embodiments device 100 features a therapeutic substance 102 that may be fit along at least one layer of pad 105 and most preferably about at least one of the second layer 105b and / or third layer 105c. Optionally therapeutic substance 102 may be dispersed in any manner along pad 105 and / or any sublayer thereof 105a, 105b, 105c.

[0141] In embodiments, therapeutic substance 102 may be associated with device 100 via support fibers 104 wherein the therapeutic substance 102 is infused and / or coated and / or associated and / or affixed with at least a portion of the support fibers 104, for example as shown in FIG. 4C.

[0142] In embodiments, therapeutic substance 102 may be provided in optional forms and / or states for example including but not limited to solid, liquid, gel, vapor, the like, or any combination thereof. In embodiments, therapeutic substance 102 may be provided in the form of a solid and / or gel that is sporadically spaced about pad 105 and along support fibers 104.

[0143] In a preferred embodiment therapeutic substance 102 may be provided in solid form and heated, for example with a heat generating source 106, to assume its liquid and / or gel and / or vapor forms in preparation for delivery through adhesive layer 105a over the treatment area 5 comprising a portion of the skin.

[0144] In embodiments therapeutic substance 102 may be provided as an oil and / or medicament, formulation and / or preparation that is configured to be delivered to the treatment area 5 over portion of the skin through the adhesive layer 105 a.

[0145] In some embodiments, therapeutic substance 102 may be configured to be a pressure sensitive material that is activated to with a change of pressure. Forexample, pressure applied onto therapeutic substance 102, optionally via support fibers 104, may cause the release of the therapeutic substance 102 or to assume a flowing form thereof so as to facilitate delivery of the therapeutic substance 102 to a treatment area 5 over a portion of the skin.

[0146] In embodiments, therapeutic substance 102 may be provided from optional preparations and / or formulations that are configured for facilitating treatment of the treatment area, for example to increase the treatment areas flexibility and / or stretchability to maintain the treatment area moist and / or pliable. In embodiments the therapeutic substance may comprise at least one or more active materials and / or therapeutic substance. In embodiments the therapeutic substance may for example include at least one or more selected from the group comprising Perineum oil, Almond oil, Argan oil, Coconut Oil, Olive Oil, Shea Butter, Jojoba Oil, Creams and lotions containing collagen, Ointment or liquid with green tea, Niacinamide, Centella Asiatica, Squalane, Hyaluronic acid, Polyhydroxy Acids (PHA), Lactic Acid, Ceramides, Dimethicone, Edelweiss Extract, Oat, oat butter, Algae, Witch Hazel, Alpha Hydroxy Acid (AHA), Salicylic Acid (BHA), PROPYLENE, GLYCOL, CAPRYLIC / CAPRIC TRIGLYCERIDE. Urea. Aloe, the like or any combination thereof.

[0147] In embodiments, device 100 comprises a thermal energy generating source 106, that may optionally be provided in the form of a heating element, a heat conducting element or an exothermic reaction source. In embodiments, thermal energy generating source 106 provides for the transfer of thermal energy either directly or indirectly toward the treatment area 5.

[0148] In embodiments thermal energy generating source 106 is more preferably disposed on the third layer 105c.

[0149] In embodiments thermal energy generating source 106 may be associated with support fibers 104 so as to facilitate the transfer of thermal energy thereto and onto treatment area 5.

[0150] In embodiments thermal energy generating source 106 may be activated to generate thermal energy with a control and / or activating signal received from at least one of electronics module 110 and / or an optional auxiliary device 20.

[0151] In embodiments thermal energy generating source 106 may be configured to generate thermal energy within a temperature range of about 34 degrees Celsius andup to about 38 degrees Celsius, and to maintain the energy generating activity for a period of time equivalent at least 3 hours.

[0152] In some embodiment device 100 that is disposed over the treatment area 5, for example including but not limited to the female perineal anatomy as best seen in FIG. 5-8, may further comprise a fetal heart rate (FHR) sensor 124 that is configured for detecting fetal heart rate as deciphered from the maternal heart rate. Most preferably, FHR sensor is communication with at least one of the electronics module 110 and / or an optional auxiliary device 20. Optionally and preferably FHR sensor 124 provides for monitoring fetal heart rate during pregnancy and / or childbirth. Optionally FHR sensor 124 in use with electronics module 110 may be configured to monitor the fetal heart rate so as to determine an alarm state which may be communicated for example via communication module 116 to at least one or more optional auxiliary devices 20 for example including but not limited to : a smartphone, a communication device, a medical service provider, a vital signal(s) monitor, a monitor, a call center, first respondent emergency services, a health care system server, or the like.

[0153] In embodiments electronics module 110 may comprise a plurality of optional sub-modules for example including but not limited to a power supply module 112, controller and / or processor module 114, user interface module 111, and memory module 118. Optionally electronics module 110 may further comprise a communication module 116. Electronics module 110 may further comprise or functionally associated with a sensor module 120.

[0154] In embodiments electronics module 110 is more preferably associated with third layer 105c.

[0155] In embodiments, User Interface (UI) module 111 may provide a user with means for interfacing with device 100 preferably via processor module 114. User interface Ill is preferably provided in the form of an audiovisual display, a non limiting example of which may be provided in the form of a light emitting diode (LED) and / or a LED array, and / or a LED display and / or an LED indicator(s). In some embodiments the UI module 111 may be provided in optional forms for example including but not limited to keyboard, display, touch screen, touch pad, buzzer, tactile pad, at least one light emitting diode (LED), at least one organic LED (OLED), speakers, microphone, the like or any combination thereof.In embodiments UI module 111 may be provided to communicate an alarm state associated with any portion of the device 100. For example, UI 111 in the form of a LED indicator may be utilized to communicate a visual alarm state that may for example include indication of above threshold forces. For example, an alarm state with respect to the FHR sensor 124 may be communicated to a user and / or a caregiver via UI module in either visual format via a display and / or audible format via a speaker. For example, UI 111 may be provided in the form of a speaker that may be utilized to be audible to a user to communicate with a user to provide user instructions or convey information to a user or the like.

[0156] In embodiments processor module 114 may be configured to provide the necessary processing hardware and / or software necessary to render at least a portion of device 100 and / or system 50 functional. In embodiments controller and / or processor module 114 may provide for controlling any portion of device 100 and / or system 50 and / or thermal energy generating source 106. For example, processor 114 may be utilized to determine the status of the at least one or more sensors comprising sensor module 120.

[0157] In embodiments power module 112 preferably provides the necessary hardware and / or software to power any portion of device 100 and / or thermal energy generating source 106. In some embodiments power module 112 may be utilized to power any portion of device 100 and / or system 50 therein rendering device 100 and system 50 operational. In embodiments power supply 112 may for example be provided in optional forms for example including but not limited to battery, rechargeable induction battery, induction coil, capacitors, super capacitors, photovoltaic cell, the like power source or any combination thereof.

[0158] In embodiments communication module 116 provides the necessary hardware and / or software to facilitate communication for device 100 and system 50 to communicate with optional auxiliary devices 20. For example, an auxiliary device 20 may for example include but is not limited to at least one selected from the group comprising: a smartphone, mobile processing and communication device, imaging device or system, medical imaging device or system, a health monitoring device, a monitor, a server, a computer, a healthcare service provider dedicated system, a first respondent call center, a health care call center, the like or any combination thereof.

[0159] In some embodiments communications module 116 may be utilized to provide device 100 and / or system 50 with communication capabilities. For example,communication sub-module 116 may provide for facilitating communication with an optional auxiliary devices and / or systems by utilizing various communication protocols for example including but not limited to wireless communication protocols, cellular communication, wired communication, near field communication (NFC), BLUETOOTH™, optical communication, the like and / or any combination thereof.

[0160] In optional embodiments electronics module may further comprise a memory module 118 configured to provide the necessary hardware and / or software to facilitate operations of device 100 and / or system 50 by enabling storing and / or retrieving stored data and / or the like as is known in the art.

[0161] In embodiments sensor module 120 provides the necessary hardware and / or software to facilitate operations of at least one or more sensor(s) associated with device 100 and / or system 50 to enable sensing various events in and around device 100. In embodiments sensor module 120 may comprise at least one or more sensor selected from the group consisting of: fetal heart rate sensor (FHR) 124, temperature sensor, pH sensor, galvanic skin conductance sensor, heart rate sensor, flow-meter, pulse oximeter, piezoelectric pressure sensor, pressure sensor, electrical resistance, magnetic field, length, electrical conductance, force sensor, the like or any combination thereof.

[0162] FIG. 9A-C shows an example of a patch 100 according to embodiments of the present invention wherein the support fibers 104 are arranged to provide a support gradient along the length of the female perineum from the vagina to the anus. In embodiments, the gradient is configured such that the sticker is formed from a plurality of regions having support fibers 104 having of variable flexibility.

[0163] FIG. 9 A shows patch 100, shaped to fit the perineum, having integrated support fibers 104 featuring a “V” shaped support gradient along the length of the perineum between the anus and vagina.

[0164] FIG. 9B shows a partial exploded view of patch 100 to show the three support layers 105a,b,c as previously described. Most preferably layer 105b comprises the support fibers 104 that are embedded within a transparent support matrix, for example provided from thermoplastic polyurethane (‘TPU’) or the like material that are capable of associating and / or integrating and / or supporting the optional support fibers 104 so as to allow the embedded support fibers to expand as necessary while remaining integrally formed with the transparent support matrix.As schematically shown in FIG. 9C, the support fibers 104 are arranged along the length of the perineum to provide increased flexibility adj acent to the vagina while gradually reducing flexibility toward the anus. Such an arrangement is provided so as to reduce the likelihood of a tear about the perineum and in particular to provide most support near the anus so as to avoid and / or reduce to a minimum any perineal tears from reaching the anus. Accordingly, as shown the support fibers are divided into 6 regions noted A, B, C, D, E and F spanning the perineum. As appreciated by a skilled artisan the number of regions utilized is not limited to 6 regions, wherein alternatively the patch may comprise at least two regions; optionally at least three or more regions may be utilized to form the expansion gradient.

[0165] In embodiments, region A, proximal to the vagina, is provided from fibers having maximal enlargement and / or expansion and / or directional flexibility, of up to about 200%, therein fibers 104 forming region A can expand to up to about their original length. Region F, proximal to the anus, comprises support fibers 104 that are configured to have minimal enlargement and / or expansion and / or directional flexibility preferably of about 0%, and therein maintain their original length. In embodiments, intermittent regions comprising regions B, region C, region D, and region E, may be configured to have respectively lowing degree of enlargement and / or expansion and / or directional flexibility such that region B is provided with support fibers configured to have degree of enlargement and / or expansion and / or directional flexibility of about 160%, therein may expand by up to about 60% of their original length;

[0166] region C is provided with support fibers configured to have a degree of enlargement and / or expansion and / or directional flexibility of about 140%, therein may expand by up to about 40% of their original length;

[0167] region D is provided with support fibers configured to have a degree of enlargement and / or expansion and / or directional flexibility of about 120%, therein may expand by up to about 20% of their original length; and

[0168] region E is provided with support fibers configured to have a degree of enlargement and / or expansion and / or directional flexibility of about 110%, therein may expand by up to about 10% of their original length.

[0169] Most preferably such fiber arrangement provides for generating a “V” shaped expansion gradient along the length of the perineum so as to provide maximal support and in particular protect the perineal region adjacent to the anus.As used herein the term “about” refers to + / -10 %.

[0170] The terms "comprises", "comprising", "includes", "including", “having” and their conjugates mean "including but not limited to". The term “consisting of’ means “including and limited to”. The term "consisting essentially of means that the composition, method or structure may include additional ingredients, steps and / or parts, but only if the additional ingredients, steps and / or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.

[0171] The word “exemplary” is used herein to mean “serving as an example, instance or illustration”. Any embodiment described as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments and / or to exclude the incorporation of features from other embodiments.

[0172] The word “optionally” is used herein to mean “is provided in some embodiments and not provided in other embodiments”. Any particular embodiment of the invention may include a plurality of “optional” features unless such features conflict.

[0173] As used herein, the singular form "a", "an" and "the" include plural references unless the context clearly dictates otherwise. For example, the term "a compound" or "at least one compound" may include a plurality of compounds, including mixtures thereof.

[0174] Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.

[0175] Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases “ranging / ranges between” a first indicate number and a second indicate number and “ranging / ranges from” a first indicate number “to” a second indicate number are usedherein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.

[0176] In those instances where a convention analogous to "at least one of A, B, and C, etc." is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., "a system having at least one of A, B, and C" would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and / or A, B, and C together, etc.). It will be further understood by those within the art that virtually any disjunctive word and / or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase "A or B" will be understood to include the possibilities of "A" or "B" or "A andB."

[0177] As used herein the term "method" refers to manners, means, techniques and procedures for accomplishing a given task including, but not limited to, those manners, means, techniques and procedures either known to, or readily developed from known manners, means, techniques and procedures by practitioners of the chemical, pharmacological, biological, biochemical and medical arts.

[0178] There are many inventions described and illustrated herein. The present inventions are neither limited to any single aspect nor embodiment thereof, nor to any combinations and / or permutations of such aspects and / or embodiments. Moreover, each of the aspects of the present inventions, and / or embodiments thereof, may be employed alone or in combination with one or more of the other aspects of the present inventions and / or embodiments thereof. For the sake of brevity, many of those permutations and combinations will not be discussed separately herein.

[0179] While the invention has been described with respect to a limited number of embodiment, it is to be realized that the optimum dimensional relationships for the parts of the invention, to include variations in size, materials, shape, form, function and manner of operation, assembly and use, are deemed readily apparent and obvious to one skilled in the art, and all equivalent relationships to those illustrated in the drawings and described in the specification are intended to be encompassed by the present invention.

[0180] Therefore, the foregoing is considered as illustrative only of the principles of the invention. Further, since numerous modifications and changes will readily occurto those skilled in the art, it is not described to limit the invention to the exact construction and operation shown and described and accordingly, all suitable modifications and equivalents may be resorted to, falling within the scope of the invention.

[0181] It should be noted that where reference numerals appear in the claims, such numerals are included solely or the purpose of improving the intelligibility of the claims and are no way limiting on the scope of the claims.

[0182] Having described a specific preferred embodiment of the invention with reference to the accompanying drawings, it will be appreciated that the present invention is not limited to that precise embodiment and that various changes and modifications can be effected therein by one of ordinary skill in the art without departing from the scope or spirit of the invention defined by the appended claims.

[0183] It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable sub-combination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.

[0184] Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the scope of the appended claims.

[0185] Citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the invention.

[0186] Section headings are used herein to ease understanding of the specification and should not be construed as necessarily limiting.

[0187] While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications and other applications of the invention may be made.

Claims

CLAIMSWhat is currently claimed is:1) An adhesive patch (100) adapted for supporting a portion of skin (5) and its underlying tissue structures, the device comprising:a) a multilayered pad (105) comprising at least three layers:i) a first layer (105a) in the form of a fine mesh adhesive layer;ii) a second layer (105b) comprising at least one therapeutic substance (102) that is delivered to the underlying portion of skin (5) layer; and wherein the second layer features supporting fibers (104) that are associated with the at least one therapeutic substance (102) and configured to be delivered to the portion of skin through the first layer;iii) a third layer (105c) featuring a thermal energy generating source (106) that is configured to provide thermal energy and sufficient to facilitate the delivery of said therapeutic substance (102) to the portion of skin from said second layer through said first layer; andb) a sensor module (120).2) The adhesive patch of claim 1 wherein said supporting fibers forming said second layer are arranged in at least two dimensions.3) The adhesive patch of claim 1 wherein the therapeutic substance is configured to be delivered in a flowing fluid form at a temperature of about 37 degrees.4) The adhesive patch of claim 1 wherein the thermal energy generating source is activated by at least one or more activation source selected from: an electromagnetic signal, electromagnetic wave, electromagnetic energy, pressure wave, application of mechanical pressure, signal from at least sensor, signal received from an external mobile communication and processing device, a light source, an acoustic energy source, communication signal received from an external processing device, or any combination thereof.5) The adhesive patch of claim 1 wherein the therapeutic substance is temperature activated by ambient temperature of the portion of skin.6) The adhesive patch of claim 1 wherein the therapeutic substance is configured to have fluid flow properties at a temperature range from about 34 degrees Celsius and up to about 38 degrees Celsius.7) The adhesive patch of claim 1 wherein the therapeutic substance is configured to have at least one of a sublimation point, or melting point, or evaporation point within a temperature range of about 34-38 degrees Celsius.8) The adhesive patch of claim 1 comprising at least two or more different therapeutic substance.9) The adhesive patch of claim 1 wherein at least one dimension of the patch may be from 1.5 cm (centimeters) and up to about 4 cm (centimeters).10) The adhesive patch of claim 1 wherein at least one dimension of the patch is controlled by folding portions of the patch onto itself.11) The adhesive patch of claim 1 configured to be formed from a plurality of subsegments (100a,b,c,p).12) The adhesive patch of claim 11 wherein the patch is formed from a plurality of subsegment that are associated with one another over the portion of skin.13) The adhesive patch of claim 1 is configured to be shaped according to a portion of the human or animal anatomy.14) The adhesive patch of claim 13 wherein configured to be shaped according to the female perineal and vaginal anatomy.15) The adhesive patch of claim 14 wherein a first sub-segment (100c) is shaped corresponding to the external vaginal surface anatomy; and a second sub-segment (lOOp) is shaped corresponding to the perineal surface / anatomy.16) The adhesive patch of claim 1 wherein the support fibers are configured to expand or contract along its long axis by up to 200% of its initial length.17) The adhesive patch of claim 1 wherein support fibers are arranged in an overlapping configuration.18) The adhesive patch of claim 16 or 17 wherein said support fibers have a geometric configuration selected from at least one of: circular, square, triangular, polygonal of at least 3 sides, oval, ovoid, elliptical, braided, or any combination thereof. 19) The adhesive patch of claim 17 wherein said support fibers have an overlapping configuration that is asymmetric.20) The adhesive patch of claim 17 wherein said support fibers have an overlapping configuration that is symmetric.21) The adhesive patch of claim 1 wherein the support fibers are provided from materials selected from: smart polymers, smart materials, smart alloys, shape memory materials, or any combination thereof.22) The adhesive patch of claim 1 wherein the support fibers are coated or infused with the therapeutic substance.23) The adhesive patch of claim 1 wherein the second layer comprises at least two sublayers including:a) a first sub-layer (105bi) having support fibers arranged in a first orientation; b) a second sub-layer (105bii) having support fibers arranged in a second orientation that is orthogonal to said first fiber orientation.24) The adhesive patch of claim 2 further comprising a third sub-layer (105biii) having support fibers arranged in a third fiber orientation that is orthogonal to both said first fiber orientation and said second fiber orientation.25) The adhesive patch of claim 1 wherein said sensor module comprises a Fetal Heart Rate (FHR) sensor (124).26) The adhesive patch of claim 1 further comprising an electronics module (110). 27) The adhesive patch of claim 26 wherein said electronics module includes a communications module configured to be in communication with an auxiliary device (50).28) The adhesive patch of claim 1 wherein the thermal energy generating source (106) is configured to provide thermal energy to the treatment area equivalent to 38 degrees Celsius for up to 3 hours.29) A method for supporting a portion of skin with the adhesive patch according to claim 1, the method comprising:a) applying at least a portion of the adhesive patch with the adhesive layer over a treatment area comprising the female vaginal anatomy;b) applying at least a portion of the adhesive patch over a treatment area comprising at least a portion of skin of the female perineal anatomy; and c) activating the thermal energy generating source (106) configured to facilitate mobilizing fluid flow properties of at least one or more therapeutic substance (102) toward the treatment area.30) A method for supporting a portion of skin with the adhesive patch according to claim 1, the method comprising:a) applying at least a portion of the adhesive patch with the adhesive layer over a treatment area comprising the female vaginal anatomy or female perineal anatomy;b) limiting the expansion of the treatment area with the support fibers (104) wherein the support fibers are shaped so as to encourage the flexibility of the support fiber (104) along at least one or more axis; wherein the support fiber length is configured to self-adjusted by expansion or contraction by up to 200% of its initial length.31) An adhesive patch (100) adapted for supporting a portion of skin (5) and its underlying tissue structures, the device comprising:a) a multilayered pad (105) comprising at least three layers:i) a first layer (105a) in the form of a fine mesh adhesive layer;ii) a second layer (105b) comprising supporting fibers (104) that are configured to form an expansion gradient along at least one dimension along the portion of skin (5); and wherein expansion gradient provides an expansion gradient of the supporting fibers (104) from 0% and up to about 200% wherein the supporting fibers (104) are configured to expand or contract along its long axis by up to 200% of its initial length;iii) a third layer (105c) featuring a thermal energy generating source (106) that is configured to provide thermal energy to the portion of skin (5).32) The adhesive patch of claim 31 wherein the wherein expansion gradient is formed by utilizing a plurality of regions comprising support fibers having different degree of expansion within each region.33) The adhesive patch of claim 32 comprising at least two or more expansion regions, wherein each expansion region features supporting fiber having different expansion characteristic.34) The adhesive patch of claim 31 further comprising a sensor module (120).35) The adhesive patch of claim 31 wherein said second layer (105b) comprises at least one therapeutic substance (102); and wherein said at least one therapeutic substance (102) is associated with said supporting fibers (104); and wherein said at least onetherapeutic substance (102) is configured to be delivered to the portion of skin through the first layer.36) The adhesive patch of claim 31 further comprising an electronics module (110).37) A kit for facilitating women during childbirth, the kit comprising:a) at least one or more adhesive patch according to claim 1 or 31;b) at least one thermal energy generator(s); andc) at least one or more therapeutic substance.38) The kit of claim 37 further comprising at least one or more power source in the form of a battery.